Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Labeling errors & mix-ups

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose.

1,411 FDA drug recalls with this cause, newest first.

This is exactly what it sounds like: the wrong label on the right product, the wrong strength printed on the bottle, a missing or illegible lot number and expiry date, or two products mixed up during packaging. It is dangerous precisely because the pill or liquid itself may be fine, yet the patient has no way of knowing what they are actually taking. A high share of the Class I recalls in this group are mix-ups where a stronger product ended up in a weaker product's packaging.

Class I · High risk

POTASSIUM CHLORIDE Inj.

Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container.

Ongoing Labeling / mix-up ICU Medical, Inc. NDC 0990-7075-26 D-0267-2025
Class III · Low risk

Badger 50

Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.

Terminated Labeling / mix-up The W.S. Badger Company, Inc. D-0209-2025
Class I · High risk

Adrenalin Chloride Solution

Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

Ongoing Labeling / mix-up ENDO USA, Inc. NDC 42023-103-01 D-0223-2025
Class III · Low risk

Diphenhydramine HCl 50 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8026-02 D-0199-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-2 D-0198-2025
Class III · Low risk

Diphenhydramine HCl 25 mg

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8028-1 D-0197-2025
Class III · Low risk

Acetaminophen

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

Ongoing Labeling / mix-up Akron Pharma, Inc. NDC 71399-8014-01 D-0195-2025
Class I · High risk

Clonazepam Orally Disintegrating Tablets

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Ongoing Labeling / mix-up Endo USA, Inc. D-0181-2025
Class I · High risk

Clonazepam Orally Disintegrating Tablets

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Ongoing Labeling / mix-up Endo USA, Inc. D-0180-2025
Class I · High risk

Clonazepam Orally Disintegrating Tablets

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Ongoing Labeling / mix-up Endo USA, Inc. D-0179-2025
Class I · High risk

Clonazepam Orally Disintegrating Tablet

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Ongoing Labeling / mix-up Endo USA, Inc. D-0178-2025
Class III · Low risk

Acetaminophen

Label mix-up: Carton incorrectly labeled.

Terminated Labeling / mix-up Granules Consumer Health Inc. D-0627-2024
Class I · High risk

Healthy Living Acetaminophen

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Ongoing Labeling / mix-up Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class I · High risk

Clonazepam Orally Disintegrating Tablets

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

Terminated Labeling / mix-up Endo Pharmaceuticals, Inc. NDC 49884-306-02 D-0622-2024
Class I · High risk

Acetaminophen Injection

Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found inside an overwrap labeled Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL)

Ongoing Labeling / mix-up Hikma Pharmaceuticals USA Inc. NDC 0143-9386-01 D-0635-2024